Stay updated on INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial page.

Latest updates to the INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial page
- Check2 days agoChange DetectedThe webpage has updated its date references, removing older dates from February 2025 and adding new dates in March 2025.SummaryDifference0.6%
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe webpage has updated its date listings to include new dates in February 2025, while removing older dates from January 2025. Additionally, a notice regarding service performance and availability has been removed.SummaryDifference2%
- Check45 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check52 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check59 days agoChange DetectedNew dates have been added for January 2025, while several dates from December 2024 have been removed.SummaryDifference0.9%
- Check66 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
Stay in the know with updates to INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial page.